glucose monitoring Archives

AppWizard

December 11, 2025

Tandem Mobi’s Android App Receives FDA Approval

On November 10, 2025, the Tandem Mobi insulin pump system received FDA approval for compatibility with Android smartphones, expanding access to its mobile app for both Apple and Android users. The Tandem Mobi is an automated insulin delivery system that adjusts insulin doses based on real-time blood sugar data from a continuous glucose monitoring system. It utilizes Control-IQ+ technology, which has shown users achieving up to 79 percent time in range during the day and 90 percent overnight. The mobile app allows users to manage diabetes directly from their smartphones and facilitates secure communication with healthcare providers. Nationwide access to the Tandem Mobi system is expected to begin in early 2026, with a limited release in December 2025, and the Android app will be available on the Google Play Store for select smartphone models.

AppWizard

November 22, 2025

Why Tandem Diabetes Care (TNDM) Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next

Tandem Diabetes Care has received FDA clearance for the Android version of the Tandem Mobi mobile app, set for limited release in December 2025 and broader availability in early 2026. This app will enhance accessibility to Tandem’s automated insulin delivery system for users with compatible Android smartphones. The company plans to launch the t:slim X2’s integration with Abbott’s FreeStyle Libre 3 Plus CGM sensor in October 2025, aiming to attract more continuous glucose monitoring users. Analysts project Tandem Diabetes Care could achieve .2 billion in revenue and .4 million in earnings by 2028, assuming a 7.5% annual revenue growth rate. Fair value estimates for the stock range from .64 to .57 per share, indicating a potential downside from its current market price.

AppWizard

November 11, 2025

FDA clears Android version of Tandem Mobi mobile application

The US FDA has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi mobile application, allowing users to manage diabetes from compatible smartphones. The app operates on Control-IQ+ technology and connects securely with the Tandem Mobi insulin pump and Tandem Source platform, improving communication between healthcare providers and patients. The Tandem Mobi insulin pump is designed for subcutaneous insulin delivery and is approved for patients aged two years and older. A limited release of the Android app is scheduled for next month, with commercial availability expected in early 2026. Users can download the app from the Google Play Store on compatible devices, including Google Pixel 6 through 10 and Samsung Galaxy S21 through S25. Additionally, Tandem Diabetes Care announced that its t:slim X2 insulin pump will be compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose monitoring sensor.

AppWizard

June 20, 2025

New Android 16 update could impact Dexcom G6 mobile app usage, Dexcom warns

Dexcom has warned that users of its G6 continuous glucose monitoring (CGM) app should avoid downloading the Android 16 operating system update, as it may disrupt app functionality. Users of the Dexcom G7 will not be affected by this update. The Android 16 update is currently available for select Android smartphones, and ignoring the warning could lead to issues with app performance critical for diabetes management.

AppWizard

October 28, 2024

This unreleased, ‘highly-secretive’ Apple app could help you avoid diabetes someday

Apple is internally testing a food-logging application aimed at helping users manage their dietary habits and blood sugar levels, particularly for prediabetic individuals. Participants in the testing are logging food intake and blood sugar measurements to analyze the impact of different foods on glucose levels. There are ongoing efforts to integrate these insights into the Apple Health app. Additionally, Apple has been working on a noninvasive glucose tracking feature for the Apple Watch, but its launch is uncertain due to technical challenges. The potential food-logging capabilities could provide tailored dietary recommendations for users at risk of diabetes.